Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pietra

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Blood|May 3, 2011
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progressionThorsten Klampfl, Ashot Harutyunyan, Tiina Berg, et al.
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Blood|March 30, 2017
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosisPaola Guglielmelli, Annalisa Pacilli, Giada Rotunno, et al.
Blood|April 12, 2013
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasmsElisa Rumi, Daniela Pietra, Paola Guglielmelli, et al.
Leukemia|October 14, 2020
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosisBarbara Mora, Claudia Siracusa, Elisa Rumi, et al.
American Journal of Hematology|June 7, 2016
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patientsPaola Guglielmelli, Giada Rotunno, Annalisa Pacilli, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Blood|April 21, 2017
Clinical significance of somatic mutation in unexplained blood cytopeniaLuca Malcovati, Anna Gallì, Erica Travaglino, et al.
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
Blood|June 28, 2014
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasiaLuca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Blood|May 3, 2011
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progressionThorsten Klampfl, Ashot Harutyunyan, Tiina Berg, et al.
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Blood|March 30, 2017
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosisPaola Guglielmelli, Annalisa Pacilli, Giada Rotunno, et al.
Blood|April 12, 2013
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasmsElisa Rumi, Daniela Pietra, Paola Guglielmelli, et al.
Leukemia|October 14, 2020
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosisBarbara Mora, Claudia Siracusa, Elisa Rumi, et al.
American Journal of Hematology|June 7, 2016
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patientsPaola Guglielmelli, Giada Rotunno, Annalisa Pacilli, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Blood|April 21, 2017
Clinical significance of somatic mutation in unexplained blood cytopeniaLuca Malcovati, Anna Gallì, Erica Travaglino, et al.
American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.
Blood|June 28, 2014
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasiaLuca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Pageof 10